Find verified buyers and importers for
Pharmaceutical compounds (bulk)
India exported $360 million of Pharmaceutical compounds (bulk) (HS 3003) in FY25-26 (DGFT). The top export markets are USA, UK, UAE, GERMANY, JAPAN. HS 3003 covers medicaments consisting of two or more constituents mixed for therapeutic use, not put up in measured doses. Bulk pharma compounds from Indian APIs, widely exported to regulated and semi-regulated markets. diipl turns this market intelligence into verified buyers for your product, matched to your capacity and verified before you meet, not a data list. Pick a market below for its import duty, NTM requirements, and buyer-discovery breakdown.
Looking to find buyers for your bulk pharma compounds?
See the Bulk Pharma Compounds buyer pageFind Pharmaceutical compounds (bulk) buyers by country
Each page shows import duty, NTM requirements, Indian clusters sourcing this HS code, and a step-by-step buyer-discovery guide.
Buyers for Pharmaceutical compounds (bulk) · HS 3003
Buyers for Pharmaceutical compounds (bulk) · HS 3003
Buyers for Pharmaceutical compounds (bulk) · HS 3003
Buyers for Pharmaceutical compounds (bulk) · HS 3003
Buyers for Pharmaceutical compounds (bulk) · HS 3003
Top Indian manufacturing clusters for HS 3003
Indicative cluster mapping. Data current as of FY25-26 unless otherwise noted.
Common certifications for HS 3003 exports
Certification requirements vary by destination market and sub-heading. Verify current requirements with DGFT, relevant EPCs, and the destination country's import authority before shipment.
Want a full market analysis for HS 3003?
diipl's free Market Research Report covers tariff corridors, top importers, CAGR, price benchmarks, and a recommended entry strategy.